How Long Will I Need Treatment?
Updated: Oct 1
One of the most common questions patients ask is: "How long will I need to stay on treatment?" The answer varies from person to person.
Understanding Obesity as a Chronic Condition
Many people think of weight loss as a short-term project. However, obesity is increasingly recognised as a chronic medical condition, similar to high blood pressure or type 2 diabetes. Like many chronic conditions, long-term management is often required to maintain results.
What Happens After Weight Loss?
Weight loss triggers a number of biological changes designed to encourage weight regain. These can include:
Increased hunger
Stronger cravings
Reduced feelings of fullness
Changes in energy expenditure
These responses are normal and reflect the body's natural tendency to defend its weight.
Does Everyone Need Lifelong Treatment?
Not necessarily. Some patients may eventually stop treatment. Others may continue long term to help maintain their weight and health improvements. The best approach depends on:
Your goals
Your health conditions
Your response to treatment
Your ability to maintain results off medication
The Importance of Lifestyle Changes
Medication is only one part of the picture. Developing sustainable habits around:
Nutrition
Physical activity
Sleep
Stress management
Can improve your chances of maintaining results over time.
Working With Your Medara Team
Treatment decisions should always be individualised. Your Medara doctor will work with you to review progress, discuss goals and determine the most appropriate long-term plan.
The Medara Takeaway
There is no one-size-fits-all answer. For some people, treatment may be shorter term. For others, ongoing treatment may provide the best chance of maintaining weight loss and improving long-term health.
References:
American Diabetes Association. Pharmacologic Treatment of Obesity in Adults: Standards of Care in Overweight and Obesity. 2026. In particular, its recommendation to continue effective obesity medication to maintain health benefits. DOI
Wilding JPH, et al. STEP 1 trial extension. Diabetes, Obesity and Metabolism. 2022. PubMed Central (PMC)
Aronne LJ, et al. SURMOUNT-4. JAMA. 2024.
Written and clinically reviewed by: Dr Saran Seker, MBBS (Aus), Chief Medical Officer
Last reviewed: September 2026
Comments